Angiogenesis—a new target for future therapy

Adamis, 1994, Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy, Am. J. Ophthalmol., 118, 445, 10.1016/S0002-9394(14)75794-0 Aiello, 1995, Suppression of retinal neovascularization in vivo by inhibition of VEGF using soluble VEGF-receptor chimeric proteins, Proc. Natl. Acad. Sci. U. S. A., 92, 10457, 10.1073/pnas.92.23.10457 Aiello, 1994, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N. Engl. J. Med., 331, 1480, 10.1056/NEJM199412013312203 Aiello, 1997, Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor, Diabetes, 46, 1473, 10.2337/diabetes.46.9.1473 Alon, 1995, Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nat. Med., 1, 1024, 10.1038/nm1095-1024 Arita, 2002, Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell, Circulation, 105, 2893, 10.1161/01.CIR.0000018622.84402.FF Asahara, 1995, Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery, Circulation, 91, 2793, 10.1161/01.CIR.91.11.2793 Asahara, 1999, VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells, EMBO J., 18, 3964, 10.1093/emboj/18.14.3964 Banai, 1994, Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factors in dogs, Circulation, 89, 2183, 10.1161/01.CIR.89.5.2183 Bates, 1999, Vascular endothelial growth factor and microvascular permeability, Microcirculation, 6, 83, 10.1038/sj.mn.7300054 Benjamin, 1999, Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal, J. Clin. Invest., 103, 159, 10.1172/JCI5028 Bottomley, 1999, Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha)in synovial fluid, Clin. Exp. Immunol., 117, 171, 10.1046/j.1365-2249.1999.00949.x Braverman, 1982, Role of the microcirculation in the treatment and pathogenesis of psoriasis, J. Invest. Dermatol., 78, 12, 10.1111/1523-1747.ep12497850 Braverman, 1977, Ultrastructure of the capillary loops in the dermal papillae of psoriasis, J. Invest. Dermatol., 68, 53, 10.1111/1523-1747.ep12485169 Conn, 1990, Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor, Proc. Natl. Acad. Sci. U. S. A., 87, 2628, 10.1073/pnas.87.7.2628 Creamer, 1997, Localization of endothelial proliferation of microvascular expansion in active plaque psoriasis, Br. J. Dermatol., 136, 859, 10.1111/j.1365-2133.1997.tb03925.x Detmar, 1994, Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis, J. Exp. Med., 180, 1141, 10.1084/jem.180.3.1141 Dupont, 2004, Phase I and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies, J. Clin. Oncol., 22, 14s, 10.1200/jco.2004.22.14_suppl.3009 Dvorak, 1995, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am. J. Pathol., 146, 1029 Ferrara, 1999, Clinical applications of angiogenic growth factors and their inhibitors, Nat. Med., 5, 1359, 10.1038/70928 Ferrara, 1997, The biology of vascular endothelial growth factor, Endocr. Rev., 18, 4, 10.1210/er.18.1.4 Ferrara, 1989, Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells, Biochem. Biophys. Res. Commun., 161, 851, 10.1016/0006-291X(89)92678-8 Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1, 27, 10.1038/nm0195-27 Folkman, 1992, Angiogenesis, J. Biol. Chem., 267, 10931, 10.1016/S0021-9258(19)49853-0 Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0 Gerber, 1998, Vascular endothelial growth factor induces expression of the antiapoptotic proteins. Bcl-2 and A1 in vascular endothelial cells, J. Biol. Chem., 273, 13313, 10.1074/jbc.273.21.13313 Gerber, 1998, VEGF regulates endothelial cell survival by the PI3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation, J. Biol. Chem., 273, 30336, 10.1074/jbc.273.46.30336 Goedkoop, 2004, Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study, Arthritis Res. Ther., 6, R326, 10.1186/ar1182 Griga, 1999, Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labelling of peripheral CD14+ monocytes, Dig. Dis. Sci., 44, 1196, 10.1023/A:1026640610621 Hammes, 1998, Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat, Diabetes, 47, 401, 10.2337/diabetes.47.3.401 Hernandez, 2001, Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2, J. Exp. Med., 193, 607, 10.1084/jem.193.5.607 Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994 Hollan, 2000, Researcher and regulators reflect on first gene therapy death, Nat. Med., 6, 6, 10.1038/71545 Hotta, 2000, Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients, Arterioscler. Thromb. Vasc. Biol., 20, 1595, 10.1161/01.ATV.20.6.1595 Hurwitz, 2004, Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin for the treatment of metastatic colorectal cancer, N. Engl. J. Med., 350, 2335, 10.1056/NEJMoa032691 Jakkula, 2000, Inhibition of angiogenesis decreases alveolarization in the developing rat lung, Am. J. Physiol., Lung Cell. Mol. Physiol., 279, L600, 10.1152/ajplung.2000.279.3.L600 Kasahara, 2001, Endothelial cell death and decreased expression of vascular endothelial growth factor and its receptor KDR/Flk-1 in smoking-induced emphysema, Am. J. Respir. Crit. Care Med., 163, 737, 10.1164/ajrccm.163.3.2002117 Kerbel, 2000, Tumor angiogenesis: past, present and the near future, Carcinogenesis, 21, 505, 10.1093/carcin/21.3.505 Kerbel, 2001, Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results, J. Clin. Oncol., 19, 45S Kerbel, 2002, Clinical translation of angiogenesis inhibitors, Nat. Rev., Cancer, 2, 727, 10.1038/nrc905 Kim, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo, Nature, 362, 841, 10.1038/362841a0 Kobayashi, 2004, Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin, Circ. Res., 94, E27, 10.1161/01.RES.0000119921.86460.37 Koch, 1998, Review: angiogenesis: implications for rheumatoid arthritis, Arthritis Rheum., 41, 951, 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D Kumada, 2003, Association of hypoadiponectinemia with coronary artery disease in men, Arterioscler. Thromb. Vasc. Biol., 23, 85, 10.1161/01.ATV.0000048856.22331.50 Laham, 1999, Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo controlled trial, Circulation, 100, 1865, 10.1161/01.CIR.100.18.1865 Leung, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, 246, 1306, 10.1126/science.2479986 Lind, 1993, Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia, Am. Heart J., 125, 1494, 10.1016/0002-8703(93)90446-G Lyden, 2001, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat. Med., 7, 1194, 10.1038/nm1101-1194 Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat. Med., 8, 731, 10.1038/nm724 Malecaze, 1994, Detection of vascular endothelial growth factor mRNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy, Arch. Ophthalmol., 112, 1476, 10.1001/archopht.1994.01090230090028 Marx, 2002, Cancer research. Obstacle for promising cancer therapy, Science, 295, 1444, 10.1126/science.295.5559.1444a Matsuda, 2002, Role of adiponectin in preventing vascular stenosis—THE MISSING LINK OF ADIPO-VASCULAR AXIS, J. Biol. Chem., 277, 37487, 10.1074/jbc.M206083200 Matsuzawa, 2004, Adiponectin and metabolic syndrome, Arterioscler. Thromb. Vasc. Biol., 24, 29, 10.1161/01.ATV.0000099786.99623.EF Noon, 1997, Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure, J. Clin. Invest., 99, 1873, 10.1172/JCI119354 Okamoto, 2002, Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice, Circulation, 106, 2767, 10.1161/01.CIR.0000042707.50032.19 Orlandi, 1986, Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2 receptor, Microvasc. Res., 32, 121, 10.1016/0026-2862(86)90048-8 Ouchi, 1999, Novel modulator for endothelial adhesion molecules-adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473 Ouchi, 2001, Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages, Circulation, 103, 1057, 10.1161/01.CIR.103.8.1057 Ouchi, 2003, Association of hypoadiponectinemia with impaired vasoreactivity, Hypertension, 42, 231, 10.1161/01.HYP.0000083488.67550.B8 Ouchi, 2004, Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and akt signaling in endothelial cells, J. Biol. Chem., 279, 1304, 10.1074/jbc.M310389200 Paleolog, 2002, Angiogenesis in rheumatoid arthritis, Arthritis Res., 4, S81, 10.1186/ar575 Plouet, 1989, Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells, EMBO J., 8, 3801, 10.1002/j.1460-2075.1989.tb08557.x Post, 2001, Therapeutic angiogenesis in cardiology using protein formulations, Cardiovasc. Res., 49, 522, 10.1016/S0008-6363(00)00216-9 Presta, 1997, Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders, Cancer Res., 57, 4593 Quinn, 1993, Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium, Proc. Natl. Acad. Sci. U. S. A., 90, 7533, 10.1073/pnas.90.16.7533 Robinson, 1996, Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy, Proc. Natl. Acad. Sci. U. S. A., 93, 4851, 10.1073/pnas.93.10.4851 Rosen, 2002, Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers, Cancer Control, 9, 36, 10.1177/107327480200902S05 Rosengart, 1999, Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA, Ann. Surg., 230, 466, 10.1097/00000658-199910000-00002 Schumacher, 1998, Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease, Circulation, 97, 645, 10.1161/01.CIR.97.7.645 Sellke, 1990, Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals, Circulation, 81, 1938, 10.1161/01.CIR.81.6.1938 Sellke, 1992, Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals, Am. J. Physiol., 262, H1669 Seo, 1999, Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor, Am. J. Pathol., 54, 1743, 10.1016/S0002-9440(10)65430-2 Shafiee, 2000, Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1, Invest. Ophthalmol. Visual Sci., 41, 2378 Shibata, 2004, Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling, J. Biol. Chem., 279, 28670, 10.1074/jbc.M402558200 Shweiki, 1992, Vascular endothelial growth factor induced by hypoxia may meditate hypoxia-initiated angiogenesis, Nature, 359, 843, 10.1038/359843a0 Simons, 2000, Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary, Circulation, 102, e73, 10.1161/01.CIR.102.11.e73 Stellmach, 2001, Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor, Proc. Natl. Acad. Sci. U. S. A., 98, 2593, 10.1073/pnas.031252398 Strawn, 1996, Flk-1 as a target for tumor growth inhibition, Cancer Res., 56, 3540 Takahashi, 2002, Myogenic akt signaling regulates blood vessel recruitment during myofiber growth, Mol. Cell. Biol., 22, 4803, 10.1128/MCB.22.13.4803-4814.2002 Tomita, 1999, Autologous transplantation of bone marrow cells improves damaged heart function, Circulation, 100, II 247, 10.1161/01.CIR.100.suppl_2.II-247 Vanhoutte, 1985, Platelets, endothelium and vasospasm, Circulation, 72, 728, 10.1161/01.CIR.72.4.728 Walsh, 1998, Focally regulated endothelial proliferation and cell death in human synovium, Am. J. Pathol., 152, 691 Ware, 1997, Angiogenesis in ischemic heart disease, Nat. Med., 3, 158, 10.1038/nm0297-158 Warley, 1995, Capillary surface area is reduced and tissue thickness from capillaries to myocytes is increased in the left ventricle of streptozotocin-diabetic rats, Diabetologia, 38, 413, 10.1007/BF00410278 Wood, 2000, PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration, Cancer Res., 60, 2178 Yamauchi, 2001, The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat. Med., 7, 941, 10.1038/90984 Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat. Med., 8, 1288, 10.1038/nm788 Yilmaz, 2003, Obesity is associated with impaired coronary collateral vessel development, Int. J. Obes. Relat. Metab. Disord., 27, 1541, 10.1038/sj.ijo.0802474 Yu, 2002, Effect of p53 status on tumor response to antiangiogenic therapy, Science, 295, 1526, 10.1126/science.1068327 Yuan, 1996, Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody, Proc. Natl. Acad. Sci. U. S. A., 93, 14765, 10.1073/pnas.93.25.14765